Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) - Trial 2015-000606-20

Name: Clinical Trial 2015-000606-20
Creator: Pfizer, Inc.
Keywords: Bipolar Disorder, clinical trial

Access comprehensive clinical trial information for 2015-000606-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer, Inc. and is currently status unknown. The study focuses on Bipolar Disorder.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-000606-20

Trial Details

EU Clinical Trials Register • 2015-000606-20

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Study Focus

Disease/Condition

Bipolar Disorder

Sponsor & Location

Primary Sponsor

Pfizer, Inc.

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

Change From Baseline in Young Mania Rating Scale (YMRS) Score at Week 4

ICD-10 Classifications

Bipolar affective disorder

Bipolar affective disorder, unspecified

Other bipolar affective disorders

Bipolar affective disorder, currently in remission

Bipolar affective disorder, current episode mixed

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-000606-20

Type

Non-Device Trial